about
Comparison of the impact of human vs analogue insulins on glycosylated haemoglobin in a population with diabetes mellitus.Effectiveness and clinical inertia in the management of hypertension in patients in Colombia.Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia.High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia.Association between the use of benzodiazepines and opioids with the risk of falls and hip fractures in older adults.Evaluation of the quality of life of patients with diabetes mellitus treated with conventional or analogue insulins.Effectiveness and clinical inertia in patients with antidiabetic therapy.Use patterns of first-line inhibitors of tyrosine kinase and time to change to second-line therapy in chronic myeloid leukemia.Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis.Endpoints in strategies to reduce polypharmacy.Prescription patterns and costs of antidiabetic medications in a large group of patients.Trends in the use and cost of human and analogue insulins in a Colombian population, 2011-2015.Anticholinergic Risk and Frequency of Anticholinergic Drug Prescriptions in a Population Older Than 65.Drugs With Anticholinergic Potential and Risk of Falls With Hip Fracture in the Elderly Patients: A Case-Control StudyExtreme polypharmacy: The need to mint a new termConsistency between anticholinergic burden scales in the elderly with fracturesPotential prescribing omissions in patients with cardiovascular diseaseUse of intravenous alprostadil in patients with severe critical ischemia of the lower limbsPotentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucomaResults of the effectiveness of two piperacillin-tazobactam molecules in the real worldFactors related to excessive polypharmacy (≥15 medications) in an outpatient population from ColombiaEvaluation of Treatment Patterns and Direct Costs Associated with the Management of Neuropathic PainLipid-lowering drug prescriptions in a group of Colombian patientsPotentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patientsPotentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasiaPharmacotherapy and inappropriate prescriptions in patients with psoriasis
P50
Q39054758-2F703632-32E0-4F97-BC29-B1A720E6095FQ40445006-62B6296F-8EEC-47E1-BA7D-B4C91824B372Q40729384-D44AC24B-2AC1-4979-BCEB-30C06D7D0DA2Q42382868-30F8F8C9-28EE-4007-8FD9-DBFA794DC09FQ47567297-DF9202FC-AFDE-4518-B8FB-31E212CD5947Q47720328-58AC38D4-1CA8-4434-9F89-0E3E9893BBE9Q48121816-64AC1644-6F5B-49B0-8C3B-517FC14D1B18Q48140153-67008C64-DD2F-449E-9880-E9D92A5949D4Q48220921-D5E51026-AEFF-411B-96ED-374EDBAAD809Q48331760-C0597DB0-D137-4A21-B32C-FC7BA803A12AQ49357890-F6BA1C1E-28B2-41CA-B102-DB077AE67B68Q49822480-21A1DC40-ABFB-4B9E-A5EA-AB715AD4673FQ50239170-01D38F20-5D07-4B5E-B3AC-F3ED01372A09Q88025697-602DA9AF-BC04-4A17-BC09-26D294298C02Q89467527-C4ACD768-38FA-4684-B18C-11843685B7D5Q89857218-002330D1-8DC7-4F11-9568-C428D6698C30Q90410937-DD31D360-A0AC-4E90-BC5D-D09A721C75C8Q90619925-3AD352B3-4BF6-4BAF-B59F-1E8AEAC4CEBDQ91624707-AAFC47F8-255F-4DC5-B60D-8007309D60DDQ91654801-D66C328D-753E-4B5C-B424-0F24A4B48E68Q91890144-06372F4E-788C-4DD7-918B-055FA2826A2EQ92133084-268552E3-495C-411F-B47D-31A31E312A27Q92147621-99E2E04A-C1B4-4CB1-9420-B106CB890A13Q92163674-0AA9FEF8-49E2-4EEC-B57A-1E3BB08EE1AFQ92901656-97E39CE9-B808-4A72-B3C7-C21D440F1068Q96023799-070A315D-2946-42CA-A7AD-D4E38F017295
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jorge Enrique Machado-Alba
@ast
Jorge Enrique Machado-Alba
@en
Jorge Enrique Machado-Alba
@es
Jorge Enrique Machado-Alba
@nl
Jorge Enrique Machado-Alba
@sl
type
label
Jorge Enrique Machado-Alba
@ast
Jorge Enrique Machado-Alba
@en
Jorge Enrique Machado-Alba
@es
Jorge Enrique Machado-Alba
@nl
Jorge Enrique Machado-Alba
@sl
prefLabel
Jorge Enrique Machado-Alba
@ast
Jorge Enrique Machado-Alba
@en
Jorge Enrique Machado-Alba
@es
Jorge Enrique Machado-Alba
@nl
Jorge Enrique Machado-Alba
@sl
P106
P21
P31
P496
0000-0002-8455-0936